tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PACB is currently covered by 11 analysts with an average price target of $4.8. This is a potential upside of $3.4 (242.86%) from yesterday's end of day stock price of $1.4.
Pacific Biosciences of California's activity chart (see below) currently has 42 price targets and 60 ratings on display. The stock rating distribution of PACB is 62.07% BUY and 37.93% HOLD.
Analysts average stock forecasts to be materialized ratio is 66.13% with an average time for these price targets to be met of 221.23 days.
Highest price target for PACB is $16, Lowest price target is $8, average price target is $4.8.
Most recent stock forecast was given by JOHN SOURBEER from UBS on 16-Feb-2024. First documented stock forecast 27-Aug-2015.
Currently out of the existing stock ratings of PACB, 18 are a BUY (62.07%), 11 are a HOLD (37.93%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
12
$8.55 (247.83%)
12.5
2 months 2 days ago
1/4 (25%)
$6.26 (109.06%)
109
Hold
4 months 5 days ago
3/3 (100%)
$-4.36 (-12.69%)
129
Hold
8
$4.55 (131.88%)
9
5 months 12 days ago
6/6 (100%)
$1.2 (17.65%)
156
Buy
15
$11.55 (334.78%)
17
5 months 18 days ago
5/9 (55.56%)
$8.82 (142.72%)
123
Buy
11
$7.55 (218.84%)
14
5 months 18 days ago
2/8 (25%)
$4.82 (77.99%)
16
What is PACB (Pacific Biosciences of California) average time for price targets to be met?
Which analyst has the current highest performing score on PACB (Pacific Biosciences of California) with a proven track record?
Which analyst has the most public recommendations on PACB (Pacific Biosciences of California)?
Which analyst is the currently most bullish on PACB (Pacific Biosciences of California)?
Which analyst is the currently most reserved on PACB (Pacific Biosciences of California)?
